Stephen Chan Lam
Stephen Chan Lam
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CXD101 in Immunotherapy-related Liver Cancer | hepatocellular carcinoma | Active, not recruiting | Phase 2 | 2026-06-18 | NCT05873244 | |
| Cabozantinib in Hepatocellular Carcinoma | hepatocellular carcinoma | Active, not recruiting | Phase 2 | 2026-03-04 | NCT04588051 |